Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...

U.S. President Donald Trump threatened to impose tariffs of around 25 percent on pharmaceutical imports on Tuesday, raising ...

BioMarin's gene therapy pipeline has had setbacks, including a three-year delay in US approval of Roctavian and stalled development of PKU gene therapy BMN 307 as the Food and Drug Administration ...

The US is India’s largest export market for pharmaceuticals, accounting for over 30% of overall pharma exports in FY23-24 at ...

The "Biotechnology for the Non-Biotechnologist Training Course" conference has been added to ResearchAndMarkets.com's offering. The importance of the biotech industry has increased significantly over ...

Biogen Inc. (NASDAQ: BIIB) has steadily declined since peaking at $468.55 in 2021, as shares are trading down 70.64% from ...

Trump’s tariff threats have sent shockwaves through Indian pharma stocks, but analysts argue the real casualty could be the ...

Dividend stocks have been the backbone of market returns for over a century, contributing roughly two-thirds of total returns ...

Generic prescription drugs usually save consumers money because they are the same as the name brand, but the patent has ...

More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

Researchers at the Icahn School of Medicine at Mount Sinai have developed a powerful computational tool, named iDOMO, to improve the prediction of drug synergy and accelerate the development of ...

Researchers have developed a powerful computational tool, named iDOMO, to improve the prediction of drug synergy and accelerate the development of combination therapies for complex diseases. The study ...